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ABTRACT 
Objective: To evaluate the efficacy of methanolic extract of Clitoria ternatea leaf in experimental murine systemic aspergillosis. 
Methods: The investigation of methanolic extract of C. ternatea leaf against experimental murine systemic aspergillosis was assessed by the 
survival rates, quantitative determination of fungal burden in spleen, kidney and lung organs, histopathological evaluation and serum 
galactomannan index.  
Results: Methanolic extract of C. ternatea and amphotericin B demonstrated survival benefits over control. All untreated animals died by day 14. 
Similarly, both treated groups had significant reductions (P< 0.05) in the fungal burden of lungs, kidneys and spleen. By day 28, there was a 
complete clearance of the fungi from these organs. A decline was also observed in serum galactomannan level of treated animals.  
Conclusion: The methanolic extract of C. ternatea was effective against aspergillosis in immunocompromised mice comparable to that of 
amphotericin. This study merits further clinical investigations of this extract as well as isolation and characterization of their bioactive antifungal 
chemical constituent(s). 
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Aspergillus spp are ubiquitous in nature and are the most frequent 
opportunistic organisms producing a wide range of saprophytic and 
invasive syndromes in the lungs [1]. Infections caused by Aspergillus 
spp are increasing in importance, especially among 
immunocompromised hosts. The most commonly affected patients 
are with hematological malignancies undergoing intensive 
chemotherapy, bone marrow and stem cells transplant recipients 
who developed graft-versus-host disease [2,3]. Additionally several 
predisposing factors for development of invasive aspergillosis 
include more widespread use of solid organ transplantation, the use 
of adrenal corticosteroids, the acquired immunodeficiency 
syndrome (AIDS) [4]. 
Aspergillus niger has been infrequently described as an invasive 
pathogen in the past [5,6]. It is an agent of chronic pneumonia, 
bronchiol asthma, invasive aspergillosis (IA) and mycetoma [7]. 
Amphotericin B (AmpB) is a polyene macrolide with broad-
spectrum and potent antifungal activity [8]. Eventhough AmpB is 
still a major antifungal drug used for invasive aspergillosis 
treatment, the clinical use is sometimes limited because of adverse 
reactions such as renal toxicity, hypokalemia and anaemia [8,9]. 
Also, the appearance of resistant or multiresistant strains to exist 
agents requires the need for increased research and development of 
new drugs [10]. 
Botanically, Clitoria ternatea (butterfly pea) belongs to the family 
Fabaceae and subfamily Papilionaceae. It is a very well known 
Ayurvedic medicine used for different ailments. Its extracts 
possess a wide range of pharmacological activities including 
antimicrobial, antipyretic, anti-inflammatory, analgesic, diuretic, 
local anesthetic, antidiabetic, insecticidal, blood platelet 
aggregation-inhibiting and for use as a vascular smooth muscle 
relaxing properties [11]. The leaf extract was found to exhibit 
considerable antifungal activity against A. niger in a dose-
dependent manner with IC50 value 0.4 mg/mL. The scanning 
electron microscopy (SEM) study demonstrated irreversible 
deleterious morphological alterations on hyphae and conidiophore 
of A. niger when treated with leaf extracts [12]. The toxicity of 
methanolic extracts of C. ternatea leaf has been evaluated and 
found to be safe even at the dose of 2 g/kg [13]. Therefore, in the 
present study we investigated the therapy of leaf extract against 
murine aspergillosis induced in transiently immunocompromised 
mice. 
The raw materials of C. ternatea plant samples were collected at 
Seberang Jaya, Penang, Malaysia. A voucher specimen (No. 11006) 
has been deposited at the herbarium of School of Biological Sciences, 
USM. The leaves were separated and washed with water to remove 
dirt prior to drying at 40 °C for 3 days. Powdered (200 g) leaves 
were macerated in methanol (2 L) for 72 h under constant stirring 
conditions. The extract was then filtered through No. 1 Whatman 
filter paper and dried under partial vacuum using rotary evaporator 
(BUCHI R-110, Switzerland). 
The cyclophosphamide, amphotericin B, saline pellets were 
purchased from Merck (Darmstadt, Germany). Platelia Aspergillus 
62796, immunoenzymatic sandwich microplate assay for the 
detection of Aspergillus galactomannan antigen in serum were 
purchased from Bio-Rad (Marnes-la-Coquette, France). The A. 
niger ATCC 16508 strain were used in this study. The conidial 
suspension was adjusted to 0.8 x 106 conidia/mice by using 
hemacytometer and verified by plating on potato dextrose agar 
plates.  
Female Swiss albino mice of 4 - 5 weeks old, weighing initially about 
23 - 28 g were used. The animals were maintained on a 12-h 
light/dark cycle, at room temperature and were allowed free access 
to commercial food pellets (Gold Coin, Penang, Malaysia) and tap 
water. The animals were acclimatized for at least 1 week prior to 
experimentation. The handling and use of animals was in accordance 
with institutional guidelines and approval was obtained from the 
Animals Ethics Committee, Universiti Sains Malaysia, Penang, 
Malaysia (USM/PPSF/50 (063) Jld. 2). An immunocompromised 
state in mice was achieved by intraperitoneal injection of the 
immunosuppressive agent, cyclophosphamide (200 mg/kg). The 
immunocompromised state of the mice was confirmed with an 
examination of their blood profile [14]. Experimental aspergillosis 
was induced by an intravenous (iv) inoculation of restrained 
immunocompromised mice with 0.8 x 106 conidia/mice of A. niger 
via the lateral tail on day 3 post-cyclophosphamide 
immunosuppression [9].  
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The experiment was carried out in two parts with three groups of 
mice each. In the first part, the mortality due to aspergillosis was 
evaluated whereby infected animals (8 mice/group) were followed-
up for 28 days and their survival rates and time were recorded. In 
the second part of the experiment, the morbidity due to aspergillosis 
was evaluated whereby the infected mice (14 mice/group) were 
sacrificed on days 1, 3, 5, 7, 21 and 28 in groups of 2 each for 
determination of fungal colonization of organs (lungs, kidneys, 
spleen) by quantitative determination of fungal burden, 
histopathological evaluation and serum galactomannan index. 
Infested mice received either one of the following treatments; 
methanolic extract of C. ternatea (100 mg/kg, iv) and Amp B (1 
mg/kg, iv) daily for 5 consecutive days while control group received 
vehicle, 2 % aqueous Tween 80 (5 ml/kg, iv). Treatments were 
initiated 2h after fungal colonization and continued for 7 days. 
The quantitative measurement of fungal burden were performed by 
removing the kidneys, spleen and lungs aseptically and 
homogenized in 1 ml of sterile saline. The tissue homogenates were 
diluted and plated on PDA, and the plates were incubated at 28°C for 
48 h. The fungal burden was expressed as CFU/organ. Triplicate 
determinations were performed for each organ/group. Organ 
samples (kidneys and lungs) were fixed in 4 % buffered formalin, 
processed and sectioned by routine histologic techniques after 
paraffin embedding. Sections were then stained with either 
hematoxylin and eosin or Grocott’s methenamine silver stain (GMS). 
The galactomannan assay was performed according to the 
procedures described by [9]. Blood samples were collected for each 
sample at days 1, 3, 5, 7, 14, 21 and 28 for the determination of 
serum galactomannan concentrations (14 mice/group). Serum 
galactomannan concentrations were determined by the Platelia 
Aspergillus EIA a commercial sandwich ELISA kit, and carried out 
according to the protocol recommended by the producer (Bio-Rad). 
Enzyme immunoassay data were expressed as a serum 
galactomannan Index (GMI). The GMI for each test serum is equal to 
the OD of a sample divided by the OD of a threshold serum provided 
in the test kit. Sera with GMIs of less than 0.5 was considered 
negative. Sera with GMIs of greater than 0.5 were considered 
positive. 
Survival data were analyzed by Kaplan-Meier test and comparisons 
between groups were performed by the one-way analysis of 
variance (ANOVA) followed by Tukey-HSD post-hoc test. P values of 
<0.05 were considered significant in these analyses.  
The survival of mice infected systematically with A. niger was 
monitored up to 28 days following inoculation. All the untreated 
infected animals died by day 13th. Treatment with methanolic extract 
of C. ternatea leaf significantly improved the survival rate of the 
infected animals and exhibited zero mortality throughout the 28 days 



























Fig. 1: Survival of Aspergillus-infected untreated mice and 
treated mice with leaf extract and AmpB. The survival of C. 
ternatea leaf and AmpB treated groups are overlapping 
 
In the current murine aspergillosis model used, fungal colonization 
in organs was assessed quantitatively by enumeration of Aspergillus 
CFU and qualitatively by histology. table 1 shows the fungal burden 
in spleen, liver and kidney homogenates of the infected animals 
killed at days 1, 3, 5, 7, 21 and 28 post-infection. 
 
Table 1: Fungal burden in spleen, kidney and lung homogenates of the infected animals killed at different time intervals post-infection. 
Group Number of CFU / spleen organ (mean ± SD; n=2) 

























Group Number of CFU / kidney organ (mean ± SD; n=2) 

























Group Number of CFU / lung organ (mean ± SD; n=2) 

























n. d. – Not done, because the animals succumbed, * P < 0.05; ** P < 0.01; *** P < 0.001 when compared to untreated control animals 
 
 
Fig. 2: Histopathology of kidneys. A. niger hyphae in the kidney tissue of untreated control (A) shows the developed of hyphae. No 
evidence of hyphae development was observed in leaf extract (B) and AmpB (C) treated groups 
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Reduction of fungal spores was noticeable in leaf treated and AmpB 
treated groups. The effect of methanolic extract of C. ternatea on organ 
fungal colonization in these organs was comparable to that of AmpB. The 
fungal burden in spleen, kidneys and lungs of C. ternatea treated animals 
showed a reduction during the first week after initiation of treatment 
and complete clearance by day 14 till the end of study period. The 
complete clearance of fungal burden after C. ternatea treatment 
confirmed the irreversible deleterious morphological alterations on A. 
niger [12]. Histopathology was performed on lungs and kidneys of mice. 
Kidneys from untreated controls demonstrated development of fungal 
hyphae from day 3 onwards (fig. 2). On contrary, there was no evidence 
of hyphae development observed in both C. ternatea leaf and AmpB 
treated groups. A marked reduction of Aspergilli spores was observed in 
both lung and kidney histopathology of C. ternatea leaf extracts and 
AmpB treated groups. 
Galactomannan (GM) is a polysaccharide antigen isolated from 
Aspergillus species and was the first antigen detected in experimentally 
infected animals and in patients with invasive aspergillosis [15,16]. The 
sandwich ELISA system is currently the most sensitive method which 
detects up to 1 ng of GM/ mL of serum. The sensitivity of ELISA was 
higher than that of the polymerase chain reaction (PCR) and quantitative 
galactomannan detection is superior to PCR in diagnosing and 
monitoring invasive pulmonary aspergillosis in experimental mice 
model [17]. The detection of serum galactomannan is also an important 
indication of therapeutic response of a particular antifungal agent. A 
decrease in the concentration of GM in serum is indicative of treatment 
efficacy [15]. In the present study, untreated animals showed high GMI 
levels till day 7 post-infection (fig. 3).  
 
Fig. 3: Galactomannan levels in Aspergillus-infected untreated 
mice and treated mice with leaf extract and AmpB. 
Galactomannan level was considered negative when GMI < 0.5. 
 
* P < 0.01, indicates significant reduction of GMI level when 
compared with control alone  
^ P < 0.01, indicates significant difference of GMI level when 
compared with Amphotericin B alone 
The GMI of these animals could not be determined at day 14 onwards 
because all the animals in this group succumbed. Meanwhile, animals 
treated with methanolic extract of C. ternatea had a gradual and 
significant (P < 0.01) reduction in their GMI levels from day 1 till day 28 
of treatment. However, their GMI levels remain positive throughout the 
study period. In contrast, AmpB treatment significantly (P < 0.01) 
reduced the GMI levels and by day 14 onwards, the GMI levels were 
found to be negative. These phenomena could be due to occurrence of 
false positive during detection of serum galactomannan. It was 
mentioned previously that this false positive could be attributed to 
cross-reactivity with cyclophosphamide adsorption of dietary GM from 
damaged gut endothelium and β-lactam antibiotic usage [16].  
CONCLUSION 
In conclusion, the methanolic extract of C. ternatea is effective in 
experimental aspergillosis comparable to that of amphotericin B, as 
shown in prolonged survival of the infected mice, significant 
reduction in the fungal burden and eventually absence of A. niger in 
the spleen, lungs and kidneys. A decline of the galactomannan level 
in the serum samples was also noticed in C. ternatea treated animals 
though it remains positive throughout the study period.  
The present in vivo activity of the C. ternatea methanolic leaf extract 
against A. niger further established the in vitro activity of C. ternatea 
as already been described in literature [12]. Based on the current 
study, the C. ternatea methanolic leaf extract confirmed the 
irreversible deleterious morphological alterations to A. niger. 
Further clinical investigations of this extract as well as isolation and 
characterization of their bioactive antifungal chemicals 
constituent(s) are merited as natural plant-derived fungicides may 
be a source of new alternative active compounds, in particular with 
antifungal activity. 
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